During the past decade, II Klinika Chorob Pluc i Gruzlicy conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "II Klinika Chorob Pluc i Gruzlicy" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "II Klinika Chorob Pluc i Gruzlicy" are "EGFR Exon 19 Deletion" (1 trials), "EGFR L858R" (1 trials), "Non-small Cell Lung Cancer" (1 trials), "Nonsquamous Non-small Cell Lung Cancer" (1 trials) and "Relapsed Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "II Klinika Chorob Pluc i Gruzlicy" in a lesser frequency.

Most popular intervention types in "II Klinika Chorob Pluc i Gruzlicy" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "DS-1062a" (1 trials), "Docetaxel" (1 trials), "Irinotecan" (1 trials), "Lurbinectedin" (1 trials) and "Patritumab Deruxtecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "II Klinika Chorob Pluc i Gruzlicy" are 3 trials for "All" genders.

Currently, there are NaN active trials in "II Klinika Chorob Pluc i Gruzlicy". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in II Klinika Chorob Pluc i Gruzlicy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in II Klinika Chorob Pluc i Gruzlicy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".